c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells.

Li, Huan; Zhao, Na; Li, Yihui; Xing, Haiyan; Chen, Shuying; Xu, Yingxi; Tang, Kejing; Tian, Zheng; Wang, Min; Rao, Qing; Wang, Jianxiang

Li, Huan; Zhao, Na; Li, Yihui; Xing, Haiyan; Chen, Shuying; Xu, Yingxi; Tang, Kejing; Tian, Zheng; Wang, Min; Rao, Qing; Wang, Jianxiang.

Afiliación

Li H; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Zhao N; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Li Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Xing H; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Chen S; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Xu Y; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Tang K; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Tian Z; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Wang M; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Rao Q; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Wang J; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.

Stem Cells ; 36(11): 1685-1696, 2018 11.

Article en En | MEDLINE | ID: mdl-30106501

Asunto(s)

Leucemia Mieloide Aguda/tratamiento farmacológico; Leucemia Mieloide Aguda/patología; Células Madre Neoplásicas/efectos de los fármacos; Receptores de Trombopoyetina/metabolismo; Animales; Biomarcadores de Tumor/metabolismo; Modelos Animales de Enfermedad; Ratones; Células Madre Neoplásicas/metabolismo; Células Madre Neoplásicas/patología

Palabras clave

Acute myelogenous leukemia; Cancer stem cells; Cell surface markers; Self-renewal; c-MPL

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Leucemia Mieloide Aguda / Receptores de Trombopoyetina Límite: Animals Idioma: En Revista: Stem Cells Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google